key: cord-0737291-z66k4su4
authors: Kurahara, Yu; Kobayashi, Takehiko; Shintani, Sayoko; Matsuda, Yoshinobu; Tamiya, Akihiro; Sugawara, Reiko; Arai, Toru; Tachibana, Kazunobu; Okishio, Kyoichi; Matsui, Hideo; Tsuyuguchi, Kazunari
title: Clinical Characteristics of COVID-19 in Osaka, Japan: Comparison of the First–Third Waves with the Fourth Wave
date: 2021-09-10
journal: Respir Investig
DOI: 10.1016/j.resinv.2021.08.005
sha: fccebd1a5cd3e6c7c7e65cf080bfc8d7a4055af3
doc_id: 737291
cord_uid: z66k4su4

BACKGROUND: The fourth wave of COVID-19 in Osaka Prefecture, Japan, caused a medical crisis. Here, we aim to identify the risk factors for COVID-19 severity and compare patients between the first–third waves and the fourth wave. METHODS: We performed an observational retrospective study of COVID-19 cases at the National Hospital Organization Kinki-Chuo Chest Medical Center. RESULTS: We identified 404 patients (median age: 71.0 years [interquartile range: 56.0–80.0]), of whom 199 (49.1%) had mild disease, 142 (35.2%) had moderate disease, and 63 (15.6%) had severe disease. The overall mortality rate was 5.4% (22/404). Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were independent risk factors for moderate to severe disease. For every 1 mg/dL increase in C-reactive protein, 10 IU/L increase in lactate dehydrogenase, and 100 ng/mL increase in ferritin, the risk for moderate to severe disease increased by 18.3%, 12.9%, and 8.9%, respectively. Overall disease severity in the fourth wave was higher than in the first–third waves. However, there was no significant difference in mortality. Because of a shortage of beds, four of the 28 severe patients (14.3%) in the fourth wave could not be transferred to the advanced hospital. CONCLUSIONS: Cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort. During the fourth wave, COVID-19 severity worsened, increasing the number of patients who could not be transferred to beds for severe cases, resulting in a medical crisis in Osaka.

December 2019, and the pandemic has since spread around the world [1] . A clinical characteristic of COVID-19 is its diverse presentation, ranging from asymptomatic to fatal.

The risk of severe disease and mortality may differ based on population, period, and region.

For example, there were differences in the number of patients per wave of infections even in cities with similar population sizes. Severity and mortality also differed between waves in Osaka [2] , and in Sapporo patient characteristics differed between two waves [3] .

Osaka Prefecture is the largest metropolitan area in western Japan, with a In the present study, we aimed to identify factors influencing COVID-19 severity and assess any differences in COVID-19 patients between the first-third waves and the fourth wave of infections. Finally, we assessed the factors leading to the medical crisis in Osaka.

J o u r n a l P r e -p r o o f

We performed a single-center retrospective observational study with patients from 

The first COVID-19 case in Osaka was detected on January 29, 2020. On April 7, the Japanese government declared a state of emergency, which was lifted on May 21. Daily new cases decreased following the first wave. Although cases had begun to increase again by mid-June 2020, the government did not declare a state of emergency. The third wave began in October 2020. The government declared a state of emergency for the second time on January 7, 2021, after which the cases decreased. However, they began to increase again in April 2021 (Figure 1 ). During the fourth wave, Osaka's healthcare system became increasingly overwhelmed, with hospitals running out of beds and ventilators. For example, some patients could not be transferred to the hospital for severe cases. In addition, some mild patients who were still at home or in designated accommodation died when their condition worsened rapidly and they could not be hospitalized.

Continuous data are presented as median and interquartile range (IQR), and categorical data are presented as frequencies and proportions. We used Wilcoxon rank- J o u r n a l P r e -p r o o f

We identified 404 COVID-19 patients ( Table 1 

Overall disease severity in the fourth wave was higher than that in the first-third waves ( Table 3) . During the fourth wave, the number of mild cases halved, whereas moderate cases doubled. The proportion of moderate cases, particularly those in the 50-80 age group, increased (Figure 2) . With respect to the laboratory data, CRP, AST, LDH, and ferritin were significantly higher in fourth-wave patients than in first-third-wave patients (P < 0.01 for all). There were fewer cases of infection from a cluster than in the first-third waves (16.2% vs. 4.3%, P < 0.01). There were no fully-vaccinated patients in the present study.

During the fourth wave, remdesivir and systemic corticosteroids were widely used, based on previous efficacy ( Table 3 ) [7, 8] . Conversely, favipiravir was used less frequently, because of a lack of effective treatment evidence.

In the prefecture, the waiting list for beds for severe patients briefly reached a maximum of 94 (Figure 3) . Therefore, four of the 28 severe patients (14.3%) in our hospital could not be transferred to the advanced hospital during the fourth wave. These patients received mechanical ventilation for 2, 3, 9, and 12 days, and recovered. There was no difference in mortality between the first-third waves and the fourth wave (5.4% vs. 5.5%, P = 0.80).

J o u r n a l P r e -p r o o f

COVID-19 in patients with underlying medical conditions induced pneumonia with elevated inflammatory biomarkers. In Osaka, we observed many moderate to severe cases in the fourth wave.

We identified several inflammatory biomarkers as independent risk factors for moderate to severe disease. For example, for every 1 mg/dL increase in CRP, the risk for moderate to severe disease increased by 18.3% in our cohort. Similarly, for every 10 IU/L increase in LDH and 100 ng/mL increase in ferritin, the risk increased by 12.9% and 8.9%, respectively. Studies in Kanagawa prefecture [9] also reported that CRP was a risk factor for moderate (requiring > 1-4 L/min of oxygen) to severe (requiring > 5 L/min of oxygen)

disease. In the fourth wave, pneumonia caused by the variant of concern (VOC) resulted in severe inflammation, and many of the cases with high CRP levels suffered respiratory failure.

There were more moderate cases in the fourth wave than in the first-third waves (49.7% vs. 25.3%). However, we observed no significant increase in mortality (5.5% vs.

5.4%). The reasons could be as follows: the COVID-19 prognosis appears to be positive if the patient survives the respiratory failure phase, and evidence for the therapeutic efficacy of treatments such as systemic corticosteroids and remdesivir administration has been accumulating [7, 8] . In our study, systemic corticosteroids were administered to the 39.7%

J o u r n a l P r e -p r o o f of mild cases who exhibited extensive ground-glass shadows in both lungs, since this was projected to result in respiratory failure within a few days. Since patient treatment and outcome after transfer to the advanced hospital was not included in our cohort, it is possible that there was a difference in the actual mortality rate. However, data from Osaka prefecture reported that there was no difference in mortality between the third and fourth waves (2.6% vs. 2.8%; denominator is all SARS-CoV-2 positive subjects) [5] , which supports the validity of our data.

In contrast to the first-third waves, the fourth wave saw a rapid increase in cases, and 66.9% of the fourth-wave patients in our cohort experienced acute respiratory failure (moderate to severe). The proportion of patients requiring oxygen administration was 1.7 times higher than in the first-third waves. This resulted in a shortage of available medical staff and of beds for severe cases. The number of ICU beds in Osaka Prefecture was originally 618, of which COVID-19 patients occupied an unanticipated 75%. This caused non-COVID-19 medical services, such as emergency medicine and surgery, to halt temporarily. In the prefecture, the waiting list for beds for severe patients briefly reached a maximum of 94 (Figure 3) . In addition, observational studies conducted in Europe [13, 14] showed that the B.1.1.7

variant is associated with a higher risk of hospitalization than the conventional strain. In the present study, patients in the fourth wave were more likely to suffer from acute respiratory failure, which may be explained by the B. J o u r n a l P r e -p r o o f

Based on multivariate logistic regression analysis, cardiovascular disease, fever, dyspnea, and several inflammatory biomarkers were risk factors for moderate to severe COVID-19 in our cohort.

During the fourth wave in Osaka prefecture, COVID-19 severity was higher than in the first-third waves, resulting in a medical crisis in which a large number of patients could not be transferred to the advanced hospital for severe cases. At its peak, 20% of severely ill patients were managed at hospitals for mild to moderate cases, resulting in a staffing shortage throughout Osaka. In addition, hospital admissions for patients at home or in designated accommodations were delayed.

In future, emerging infectious diseases may become more common in urban areas in general. Securing hospital beds in the event of widespread diseases that require advanced medical care is a major issue that should be resolved. 

Infection from a cluster 46 (11.4%) 34 (17.1%) 9 (6.3%) 3 (4.8%)

Smoking history (current-or ex- The proportion of moderate cases, particularly those in the 50-80 age group, increased.

Severe COVID-19 cases in Osaka Prefecture [5] .

A Novel Coronavirus from Patients with Pneumonia in China

Characteristics of patients with novel coronavirus disease (COVID-19) during the first surge versus the second surge of infections in Osaka Prefecture

Characteristics of COVID-19 patients admitted into two hospitals in sapporo, Japan: Analyses and insights from two outbreak waves

Clinical Management of Patients with COVID-19. A guide for front-line health care workers

The Press Releases and Documents about COVID-19 Patients

Principles of confounder selection

Remdesivir for the Treatment of Covid-19 -Final Report

Dexamethasone in Hospitalized Patients with Covid-19

Clinical characteristics of Japanese patients with moderate to severe COVID-19

CMMID COVID-19 Working Group

Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Risk of hospital admission for patients with SARS-CoV-2 variant B.1.1.7: cohort analysis

Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries

The authors declare no conflicts of interest. manuscript in the subject matter of which any company, entity, or organization has an interest.

No If Yes: List the name(s) of authors and commercial entity(ies) and use as much space as necessary